Mauro Pettorruso
Overview
Explore the profile of Mauro Pettorruso including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
124
Citations
1433
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Rosso G, Benatti B, Pettorruso M, Sampogna G, Tomasetti C
Front Psychiatry
. 2024 Sep;
15:1362221.
PMID: 39267701
Depressive disorders are leading contributors to the global mental health-related burden, and they represent a challenge for real-world clinicians, due to the low rates of remission despite the high availability...
12.
dAndrea G, Miuli A, Pettorruso M, Cavallotto C, Marrangone C, Cocco A, et al.
J Affect Disord
. 2024 Sep;
367:583-588.
PMID: 39233241
Background: Treatment-Resistant Depression (TRD) affects almost 30 % of patients with Major Depressive Disorder (MDD). Esketamine Nasal Spray (ESK-NS) has recently been approved for TRD in combination with a Serotonin...
13.
Pettorruso M, Di Lorenzo G, Benatti B, dAndrea G, Cavallotto C, Carullo R, et al.
Front Psychiatry
. 2024 Aug;
15:1436006.
PMID: 39086731
Treatment-Resistant Depression (TRD) poses a substantial health and economic challenge, persisting as a major concern despite decades of extensive research into novel treatment modalities. The considerable heterogeneity in TRD's clinical...
14.
De Luca I, Di Carlo F, Burkauskas J, Dores A, Carvalho I, Gomez-Martinez M, et al.
Front Public Health
. 2024 Jul;
12:1386721.
PMID: 38962770
Background: Image and Performance-Enhancing Drugs (IPEDs) can enhance mental and physical capabilities and impact one's overall health. Initially confined in sport environments, IPEDs use has become increasingly widespread in a...
15.
Mancusi G, Miuli A, Santorelli M, Cavallotto C, Susini O, Pernaci G, et al.
Behav Brain Res
. 2024 May;
469:115046.
PMID: 38761859
Background: This systematic review aims to comprehensively explore the impact of psychostimulant substances on neurotrophic and inflammatory pathways, including brain-derived neurotrophic factor (BDNF), pro-BDNF, cortisol, dehydroepiandrosterone sulfate (DHEAS), thiobarbituric acid...
16.
Di Carlo F, Pettorruso M, Santorelli M, Cocciolillo F, dAndrea G, Di Nicola M, et al.
J Gambl Stud
. 2024 May;
40(4):2189-2200.
PMID: 38755422
The role of dopamine in the pathophysiology of gambling disorder (GD) remains incompletely understood, with disparate research findings concerning presynaptic and postsynaptic structures and dopaminergic synthesis. The aim of this...
17.
Chiappini S, Vaccaro G, Mosca A, Miuli A, Stigliano G, Stefanelli G, et al.
Neurosci Biobehav Rev
. 2024 May;
162():105691.
PMID: 38733894
The article presents a systematic literature review on the use and the psychiatric implications of over-the-counter drugs (OTC), prescription-only-medications (POM), and new psychoactive substances (NPS) within custodial settings. The searches...
18.
Chiappini S, Cavallotto C, Mosca A, Di Carlo F, Piro T, Giovannetti G, et al.
Pharmaceuticals (Basel)
. 2024 Apr;
17(4).
PMID: 38675495
Background: Dual disorders (DDs) involve the coexistence of a substance use disorder (SUD) with another mental illness, often from the psychotic and affective categories. They are quite common in clinical...
19.
Cavallotto C, Chiappini S, Mosca A, dAndrea G, Di Carlo F, Piro T, et al.
J Clin Med
. 2024 Apr;
13(8).
PMID: 38673478
: Dual disorders (DD) entail the coexistence of a substance use disorder (SUD) and another mental health condition, often within psychotic and affective disorders. This study aims to evaluate lurasidone,...
20.
DOnofrio A, Pizzuto D, Batir R, Perrone E, Cocciolillo F, Cavallo F, et al.
J Affect Disord
. 2024 Apr;
357:107-115.
PMID: 38636713
Introduction: Dopaminergic transmission impairment has been identified as one of the main neurobiological correlates of both depression and clinical symptoms commonly associated with its spectrum such as anhedonia and psychomotor...